Cargando…
Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice
The incidence of cancer is constantly increasing. Chemo/radiotherapy is one of major methods of treating cancer. Although adverse chemo/radiotherapy events, such as anemia and neutropenia, can be successfully cured, thrombocytopenia is still problematic. We constructed the Hyper-IL11 (H11) cytokine...
Autores principales: | Dams-Kozlowska, Hanna, Kwiatkowska-Borowczyk, Eliza, Gryska, Katarzyna, Lewandowska, Anna, Marszalek, Andrzej, Adamczyk, Sebastian, Kowalik, Anna, Leporowska, Ewa, Mackiewicz, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856347/ https://www.ncbi.nlm.nih.gov/pubmed/27144685 http://dx.doi.org/10.1371/journal.pone.0154520 |
Ejemplares similares
-
Designer Cytokine Hyper Interleukin 11 (H11) is a Megakaryopoietic Factor
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2013) -
A designer hyper interleukin 11 (H11) is a biologically active cytokine
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2012) -
Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model
por: Gąbka-Buszek, Agnieszka, et al.
Publicado: (2020) -
Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo
por: Florczak, Anna, et al.
Publicado: (2020) -
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
por: Kwiatkowska-Borowczyk, Eliza, et al.
Publicado: (2018)